Target intelligence / Profile preview

Novel transcript, antisense to CCDC86 (ENSG00000255959)

Target
ENSG00000255959
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

The ENSG00000255959 locus encodes a long non-coding RNA (lncRNA) termed "Novel transcript, antisense to CCDC86" or CCDC86-AS1. By annotation, it is antisense to the protein-coding CCDC86 gene, but there is no evidence supporting a direct molecular or functional role for ENSG00000255959 in cell biology or disease. It is not considered a therapeutic target, nor is it a receptor, enzyme, transporter, or transcription factor. No drugs, biomarkers, or disease associations have been reported, and the entry appears primarily as a genomic annotation with limited biological characterization. When seeking targets for drug development, protein-coding genes such as CCDC86 (coiled-coil domain-containing protein 86) may be relevant, but ENSG00000255959 itself should not be considered a target. The canonical target abbreviation for therapeutic research is CCDC86 (not ENSG00000255959). ENSG00000255959 is best described as a "novel lncRNA, antisense to CCDC86" and lacks evidence for therapeutic targeting. The target as described (ENSG00000255959) is not a receptor, enzyme, transporter, or other actionable target, and thus is not a therapeutic target. There appear to be no misspellings, but its use as a target is incorrect for most drug discovery or receptor-focused research. The gene is indexed correctly in genomic databases, but does not fulfill criteria for a therapeutic target.

Other names
CCDC86-AS1ENSG00000255959GC11M060603 (and other previous GeneCards identifiers)
02

Mechanism of action

None

03

Biological functions

Other (no well-defined or experimentally validated biological functions ascribed to this lncRNA)
04

Disease associations

Other (no validated roles in disease have been described for this transcript)

Beyond the preview

Go deeper on Novel transcript, antisense to CCDC86 (ENSG00000255959).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CCDC86 (ENSG00000255959).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call